Investor's Business Daily4d agobullish
Amgen, Up 46% This Year, Is Broadly Outperforming Its Peers. Here's What Its Earnings Say.News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3126last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
24/7 Wall St.4d agobullish
Stock Market Today: Dow Eyes 2% Jump as AMD Earnings Ease AI Spending FearsInvestor's Business Daily5d agobullish
Amgen, Up 41% This Year, Is Broadly Outperforming Its Peers. Here's What Its Earnings Say.Investor's Business Daily5d agobullish
Amgen, Up 42% This Year, Is Broadly Outperforming Its Peers. Here's What Its Earnings Say.24/7 Wall St.6d agobullish
Eli Lilly Jumped 6% After Earnings. It’s Up 68% in a Year. Where Does the Target Go Now?GuruFocus.com88d agobullish
BeOne Medicines Ltd (ONC) (Q2 2026) Earnings Call Highlights: Revenue Surges 30% to $1. ...GuruFocus.com95d agobullish
Amgen Inc (AMGN) (Q2 2026) Earnings Call Highlights: Revenue Surges Past $10 Billion, Guidance ...Investor's Business Daily115d agobullish
Dow Jones' Merck Snags A First-Of-Its-Kind Approval, And JumpsThe Wall Street Journal129d agobullish
Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage TrialThe Wall Street Journal129d agobullish
Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial